We are live on ! Find out more
AH

Andreas Halvorsen Viking Global Investors

AUM $35.1B
1-Year Est. Return 21.36%
 

Andreas Halvorsen is the founder of Viking Global Investors, another prominent firm with roots in Julian Robertson’s Tiger Management. Viking is known for fundamental long/short equity investing and a large, research-intensive platform. Its public filings are widely monitored for institutional-quality growth and cyclical equity ideas.

This Fund
S&P 500
This Quarter Est. Return
+18.19%
1 Year Est. Return
+21.36%
3 Year Est. Return
+97.07%
5 Year Est. Return
+98.11%
10 Year Est. Return
+504%
AUM
$17.4B
AUM Growth
-$131M
Cap. Flow
-$2.74B
Cap. Flow %
-15.7%
Top 10 Hldgs %
51.39%
Holding
73
New
16
Increased
19
Reduced
20
Closed
16

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$317M
2
ALGN icon
Align Technology
ALGN
+$295M
3
JD icon
JD.com
JD
+$294M
4
NVDA icon
NVIDIA
NVDA
+$293M
5
MELI icon
Mercado Libre
MELI
+$244M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$748M
2
CRM icon
Salesforce
CRM
+$709M
3
AMZN icon
Amazon
AMZN
+$586M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$453M
5
V icon
Visa
V
+$440M

Sector Composition

Rank Sector Weight
1 Healthcare 37.58%
2 Technology 15.3%
3 Consumer Discretionary 14.5%
4 Communication Services 13.31%
5 Energy 5.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EIDX
51
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$46.6M 0.27%
1,986,201
CTLT
52
DELISTED
CATALENT, INC.
CTLT
$43M 0.25%
1,060,513
-517,918
-33% -$20.2M
AJG icon
53
Arthur J. Gallagher & Co
AJG
$67.6B
$37.2M 0.21%
475,830
-724,969
-60% -$55.8M
EDIT icon
54
Editas Medicine
EDIT
$478M
$22.8M 0.13%
931,401
EQH icon
55
Equitable Holdings
EQH
$13.3B
$13.7M 0.08%
+681,600
New +$13M
NVRO
56
DELISTED
NEVRO CORP.
NVRO
$7.03M 0.04%
+112,414
New +$5.29M
ATYR
57
aTyr Pharma
ATYR
$49.2M
$1.77M 0.01%
229,283
+130,404
+132% +$929K
AAL icon
58
American Airlines Group
AAL
$9.15B
-5,759,432
Closed -$185M
ABEO icon
59
Abeona Therapeutics
ABEO
$348M
-11,741
Closed -$2.1M
AMRX icon
60
Amneal Pharmaceuticals
AMRX
$6.24B
-2,353,204
Closed -$31.8M
BA icon
61
Boeing
BA
$169B
-556,964
Closed -$180M
CGNX icon
62
Cognex
CGNX
$10.2B
-884,422
Closed -$34.2M
CP icon
63
Canadian Pacific Kansas City
CP
$85B
-2,377,135
Closed -$84.4M
CRM icon
64
Salesforce
CRM
$171B
-5,174,593
Closed -$709M
DD icon
65
DuPont de Nemours
DD
$18.7B
-2,310,127
Closed -$313M
IQ icon
66
iQIYI
IQ
$1.01B
-4,427,950
Closed -$65.8M
LEN icon
67
Lennar Class A
LEN
$21B
-259,123
Closed -$9.82M
OVV icon
68
Ovintiv
OVV
$18.5B
-1,798,508
Closed -$52M
RJF icon
69
Raymond James Financial
RJF
$33.7B
-3,740,142
Closed -$186M
SEE
70
DELISTED
Sealed Air
SEE
-849,566
Closed -$29.6M
TCOM icon
71
Trip.com Group
TCOM
$29B
-196,286
Closed -$5.31M
TMUS icon
72
T-Mobile US
TMUS
$196B
-3,452,893
Closed -$220M
Z icon
73
Zillow
Z
$8.07B
-4,651,037
Closed -$147M

Similar funds

Andreas Halvorsen's Q1 2019 Portfolio in Review

As of Q1 2019, Andreas Halvorsen held 73 positions worth $17.4B, down 0.75% from $17.6B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Andreas Halvorsen withdrew a net $2.74B in Q1 2019, closing 16 positions and reducing 20 holdings. Its most notable exit was Salesforce, an estimated $709M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Andreas Halvorsen opened a new position in JD.com worth $348M.

  • Andreas Halvorsen's largest Q1 2019 buy was JD.com: 11,552,547 shares worth $348M.
  • Andreas Halvorsen added most to Elevance Health in Q1 2019, an estimated $317M increase.
  • Andreas Halvorsen's biggest Q1 2019 reduction was Alibaba, cutting an estimated $748M.
  • Andreas Halvorsen fully exited Salesforce in Q1 2019, selling an estimated $709M.
  • Andreas Halvorsen's ten largest holdings make up 51% of its $17.4B portfolio in Q1 2019.
  • Andreas Halvorsen opened 16 new positions and closed 16 in Q1 2019.
  • Andreas Halvorsen's portfolio value fell 0.75% quarter-over-quarter to $17.4B.

Based on Viking Global Investors's 13F filing for Q1 2019, filed 15 May 2019.